| Mr Khai P Ly, PHARM D | |
|
2220 Bridgepointe Pkwy, Foster City, CA 94404-1569 | |
| (650) 393-2126 | |
| (650) 235-1022 |
| Full Name | Mr Khai P Ly |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2220 Bridgepointe Pkwy, Foster City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457619553 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 56967 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Khai P Ly, PHARM D 2220 Bridgepointe Pkwy, Foster City, CA 94404-1569 Ph: (650) 393-2126 | Mr Khai P Ly, PHARM D 2220 Bridgepointe Pkwy, Foster City, CA 94404-1569 Ph: (650) 393-2126 |
News Archive
Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have found an explanation for why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa).
New research from North Carolina State University and the University of Minnesota shows that the majority of consumers will accept the presence of nanotechnology or genetic modification (GM) technology in foods - but only if the technology enhances the nutrition or improves the safety of the food.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired Timaq Medical Imaging, a leading European provider of advanced imaging services to pharmaceutical and biotech firms.
A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with idiopathic pulmonary fibrosis (IPF).
SRI International has been awarded a five-year contract valued up to $9.75 million from the National Institute on Drug Abuse to conduct preclinical safety studies of potential new medications to treat substance abuse. SRI researchers will study potential drug-drug interactions between new treatment therapies and common drugs of abuse to assess potential adverse reactions.
› Verified 3 days ago
Rachel Borst, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Bridgepointe Pkwy, Foster City, CA 94404 Phone: 650-393-2126 | |
Laemsing Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2220 Bridgepointe Pkwy, Foster City, CA 94404 Phone: 650-393-2126 | |
Michele Bell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 919 Edgewater Blvd, Foster City, CA 94404 Phone: 650-572-1167 | |
Grace Yip, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Metro Center Blvd, Foster City, CA 94404 Phone: 650-286-0759 Fax: 650-918-2059 | |
Mr. Harry Lew, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Metro Center Blvd, Foster City, CA 94404 Phone: 650-286-0759 Fax: 650-918-2059 | |
Dan Do, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 987 E Hillsdale Blvd, Foster City, CA 94404 Phone: 650-570-4693 | |
Azadeh Azad, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1030 Pizarro Ln, Foster City, CA 94404 Phone: 650-762-4353 |